Enzyme Defects and the Skeleton

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Seventh Edition

Volumn , Issue , 2009, Pages 454-458

  Whyte, Michael P ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68149144755     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470623992.ch97     Document Type: Chapter

References (34)

1. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University 2008 Online Mendelian Inheritance in Man Available online at http://www.ncbi.nlm.nih.gov/omim/. Accessed June 27, 2008.
2. Whyte MP 2002 Hypophosphatasia: Nature's window on alkaline phosphatase function in humans. In: Bilezikian J, Raisz L (eds.) Principles of Bone Biology, 3rd ed. Academic Press, San Diego, CA, USA. (in press)
3. Whyte MP 2001 Hypophosphatasia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B (eds.) The Metabolic and Molecular Bases of Inherited Disease, 8th ed. McGraw-Hill, New York, NY, USA, pp. 5313-5329.
4. Van den Bos T, Handoko G, Niehof A, Ryan LM, Coburn SP, Whyte MP, Beertsen W 2005 Cementum and dentin in hypophosphatasia. J Dent Res 84:1021-1025.
5. Pauli RM, Modaff P, Sipes SL, Whyte MP 1999 Mild hypophosphatasia mimicking severe osteogenesis imperfecta in utero: Bent but not broken. Am J Med Genet 86:434-438.
6. Cahill RA, Wenkert D, Perlman SA, Steele A, Coburn SP, McAli-ster WH, Mumm S, Whyte MP 2007 Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. J Clin Endocrinol Metab 92:2923-2930.
7. Baumgartner-Sigl SB, Haberlandt E, Mumm S, Sergi C, Ryan L, Ericson KL, Whyte MP, Högler W 2007 Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.ll 12C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone 40:1655-1661.
8. Barcia JP. Strife CF, Langman CB 1997 Infantile hypophosphatasia: Treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization. J Pediatr 130:825-828.
9. Khandwala HM, Mumm S, Whyte MP 2006 Low serum alkaline phosphatase activity with pathologic fracture: Case report and brief review of adult hypophosphatasia. Endocr Pract 12:676-680.
10. Whyte MP, Mumm S, Deal C 2007 Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 92:1203-1208.
11. Coe JD. Murphy WA, Whyte MP 1986 Management of femoral fractures and pseudofractures in adult hypophosphatasia. J Bone Joint Surg Am 68:981-990.
12. Fallon MD, Weinstein RS, Goldfischer S, Brown DS, Whyte MP 1984 Hypophosphatasia: Clinicopathologic comparison of the infantile, childhood, and adult forms. Medicine (Baltimore) 63:12-24.
13. Henthorn PS, Raducha M, Fedde KN, Lafferty MA, Whyte MP 1992 Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc Natl Acad Sei USA 89:9924-9928.
14. Mornet E 2005 Tissue nonspecific alkaline phosphatase gene mutations database. Available online at http://www.sesep.uvsq.fr/Database.html. Accessed May 13, 2005.
15. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millan JL 2004 Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enppl, and ank: An integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164:1199-1209.
16. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millan JL, MacGregor GR, Whyte MP 1999 Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14:2015-2026.
17. Millan JL, Narisawa S, Lemire I, Loisel TP, Boileau G, Leonard P, Gramatikova S, Terkeltaub R, Pleshko Camacho N, McKee MD, Crine P, Whyte MP 2008 Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 23:777-787.
18. Henthorn PS, Whyte MP 1995 Infantile hypophosphatasia: Successful prenatal assessment by testing for tissue-nonspecific alkaline phosphatase gene mutations. Prenat Diagn 15:1001-1006.
19. Neufeld EF, Muenzer J 2001 The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B (eds.) The Metabolic and Molecular Bases of Inherited Disease, 8th ed. McGraw-Hill, New York, NY, USA, pp. 3421-3452.
20. Leroy JG, Wiesmann U 2001 Disorders of lysosomal enzymes. In: Royce PM, Steinmann B (eds.) Connective Tissue and Its Heritable Disorders. Wiley-Liss, New York, NY, USA, pp. 8494-8499.
21. Taybi H. Lachman RS 2006 Radiology of Syndromes, Metabolic Disorders, and Skeletal Dysplasias, 5th ed. Mosby, St. Louis, MO, USA.
22. Resnick D, Niwayama G 2002 Diagnosis of Bone and Joint Disorders, 4th ed. WB Saunders, Philadelphia, PA, USA.
23. Khan SA, Nelson MS, Pan C, Gaffney PM, Gupta P 2008 Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity. Am J Physiol Cell Physiol 294:C1387-C1397.
24. Muenzer J 2004 The mucopolysaccharidoses: A heterogeneous group of disorders with variable pediatric presentations. J Pediatr 144:S27-S34.
25. Schiffmann R. Brady RO 2002 New prospects for the treatment of lysosomal storage diseases. Drugs 62:733-742.
26. Braunlin EA, Stauffer NR, Peters CH, Bass JL, Berry JM, Hop-wood JJ. Krivit W 2003 Usefulness of bone marrow transplantation in the Hurler syndrome. Am J Cardiol 92:882-886.
27. Mudd SH, Levy HL, Kraus JP 2001 Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B (eds.) The Metabolic and Molecular Bases of Inherited Disease, 8th ed. McGraw-Hill, New York, NY, USA, pp. 2007-2056.
28. Green TJ, McMahon JA, Skeaff CM, Williams SM, Whiting SJ 2007 Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: A 2-y randomized controlled trial 1-3. Am J Clin Nutr 85:460-464.
29. Cagnacci A, Bagni B, Zini A, Cannoletta M, Generali M, Volpe A 2008 Relation of folates, vitamin B12 and homocysteine to verte-bral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone 42:314-320.
30. Herrmann W, Herrmann M 2008 Is hyperhomocysteinemia a risk factor for osteoporosis? Expert Rev Endocrinol Metab 3:309-313.
31. Salari P, Larijani B, Abdollahi M 2008 Association of hyperhomocysteinemia with osteoporosis: A systematic review. Therapy 5:215-222.
32. La Du BN 2001 Alkaptonuria. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B (eds.) The Metabolic and Molecular Bases of Inherited Disease, 8th ed. McGraw-Hill, New York, NY, USA, pp. 2109-2123.
33. Mannoni A, Scivi E, Lorenzini S, Giorgi M, Airó P, Cammelli D, Andreotti L, Marcolongo R, Porfirio B 2004 Alkaptonuria, ochronosis, and ochronotic arthropathy. Sem Arthrit Rheum 33:239248.
34. Culotta VC, Gitlin JD 2001 Disorders of copper transport. In: Scriver CR, Beaudet AL. Sly WS, Valle D, Childs B, Vogelstein B (eds.) The Metabolic and Molecular Bases of Inherited Disease. 8th ed. McGraw-Hill, New York, NY, USA, pp. 3105-3126